.
. YOU'RE
. YOU'RE WATCHING WZZM13 ONYOURSIDE KENT >> COUNTY HAS4@
THE SECOND HIGHEST RATE OF
EMPHYSEMA IN THE STATE IS A
SEVERE4@ FORM OF COPD OR CHRONIC
OBSTRUCTIVE PULM4@ONARY DISEASE
AND SPECTRUM4@ HEALTH IS NOW ONE
OF THE FIRST HOSPITALS IN THE
STATE TO OFFER A NONINVASIVE
SCREENING EASIER FOR THESE
PATIENTS.
DR. DONERS4@ INTERVENTIONAL
PULMONOLOGIST IS GOING TO TALK
MORE ABOUT4@.
HOW DOES IT WORK?
DR. THANK YOU, VALERIE.
WHEN WE THINK ABOUT IN THE
BRONCHO ABOUT WHAT IT IS ABOUT
PROVIDING4@ PATIENTS THAT CANNOT
BREATHE WITH4@ A MINIMALLY
INVASIVE WAY WITHOUT KOTS4@
WITHOUT BLEEDINGS IN ORDER TO
CREATE4@ SOME SORT OF ENVIRONMET
INSIDE OF THEIR CHEST IN WHICH
AIR CAN4@ GO IN EASIER AND
PATIENTS CAN GET THAT DEEP
FULFILLING BREATH IN4@ AND OF
ITSELF4@ WHEN SOMEBODY HAS
EMPHYSEMA FOR WHATEVER REASON
THEY DEVELOP THIS INABILITY TO
TAKE D4@EEP BREATHS OF THE LUNGS
ARE4@ SOMEWHAT DESTROYED.
WHAT WE DO AT SPECTRUM HEALTH
IS WE RUN4@ VERY BASIC TESTS TO
FIND OUT IF SOMEBODY COULD
BENEFIT FROM THESE IN A WAY
THAT WE JUST PUT A SMALL OR A
COUPLE OF VERY SMALL PROST4@HES@
TO EFFECTIVELY SHUT DOWN THE
AREA OF THE LUNG THAT WORKS THE
LEAST AND4@ ALLOWS FOR THE AREAS
THAT WORK BETTER TO DO WHAT
THEY'RE EXPECTED TO DO, WHICH
IS LETTING PATIENTS GO ABOUT
THEIR LIVES WITHOUT GETTING SO
BREATHLESS RIGHT4@.
BREATHING EASIER OBVIOUSLY
ALWAYS IMPORTANT TO HAVE THIS
PATIENT.
AND SO IT MUST BE BENEFICIAL TO
THEM NOT HAVE TO HAVE AN
INCISION TREATMENT THAT IT'S
NOT >>4@.
AND THEN WHEN WE THINK ABOUT
THE PATIENT JOURNEY4@, USUALLY
PATIENT STARTS IN THEIR 40S OR
50S WITH SOME BREATHLESSNESS,
SOME COUGHS AND SHORTNESS OF
BREATH AND WHEEZE.
MOST OF THEM SMOKE OR QUIT
SMOKING AND THEN THEY GO TO
THEIR DOCTORS AND THEY GET SOME
FIRST THEY GET SOME OXYGEN >>4@
SOME PULMONARY HABILITATION
WHEN THEY'RE GETTING TO THE
SIXTIES AND SEVENTIES THEN ANY
PIECE OF MACHINERY IN THE BODY
CONTINUES TO BREAK DOWN AND THE
LUNG AGE BECOMES A LITTLE MORE
THAN THE4@ CHRONOLOGICAL AGE.
AND ONCE THEY MAXED OUT ON THE
TREATMENT OF THE PRIMARY CARE
AND PULMONOLO4@GIST IN THE AREA
OF PROVIDE THEM WITH THEN4@ THEY
ARE LEFT WITH ONLY TWO OPTIONS
UNTIL VALVES CAME AS4@ A
BREAKTHROUGH DEVELOPMENT THEY
EITHER CAN GET CUT OPEN AND
TAKE THE PIECE OF THE LUNG THAT
WORKS THE LEAST OR THEY COULD
UNDERGO LUNG TRANSPLANTATION.
AS YOU CAN IMAGINE THERE'S A
LARGE AMOUNT OF PATIENTS THAT
THEY DON'T WANT TO BE CUT OPEN4@
.
THEY DON'T WANT TO SPEND DAYS
AND WEEKS IN A HOSPITAL.
THEY DON'T WANT TO TAKE
MEDICATIONS4@ FOR THE REST OF
THEIR LIVES AND THAT'S WHERE WE
CAN SEE THIS TRIAL THAT WAS
COMPLETED AND APPROVED BY THE
FDA BACK IN 20134@ WHICH WE
UNDERSTAND THAT WE'RE HERE TO
REJIGGER NOT CUTTING OPEN4@ OR
TAKING PIECES OF THE LUNG OUT.
WE DO EVERYTHING MINIMALLY
INVASIVE.
WE BRONCHOSCOPE WHICH IS A
PIECE OF TECHNOLOGY AND HOPEE
ITSELF THAT GOES THROUGH THE4@
NOW THE PROCEDURE TAKES HALF AN@
HOUR.
IT'S VERY SIMPLE.
DO AND WE MONITOR PATIENTS FOR
A COUPLE OF DAYS IN THE
HOSPITAL TO MAKE SURE THERE'S
NO COMPLICATIONS AND THE
PATIENTS GO BACK HOME AND
HOPEFULLY SLOWLY4@, STEADILY IN
THE MONTHS THEY START BREATHING
BETTER MLOOK >>4@ SUCH A
BREAKTHROUGH THE TECHNOLOGY IS
GIVING4@ US SUPERIMPOSES.
SO HOW LONG DOES THE TREATMENT
LAST?
>> THE THE BENEFIT OF4@ THE
BRONCHIAL VALVES AND
PARTICULARLY WHEN WE TALK ABOUT
ZEFRAM WHICH IS THE4@ NAME OF TE
PRODUCT, IT'S AN IMPLANT4@ OR
MANY SMALL IMPLANTS THAT ONE OF@
THE BENEFITS THAT IS NOT
PERMANENT THE BENEFITS COULD BE
PERMANENT4@ IF WE LEAVE THE
VALVES IN PLACE ALTHOUGH FOR
WHATEVER4@ REASON AND THIS
HAPPENS RARELY THE PATIENT IS
TO EXPERIENCE A COMPLICATION OF
THE4@ PROCEDURE OR MAYBE THEY
DON'T EXPERIENCE THE BENEFITS
OF THE PROCEDURE4@.
THIS IS DISAVOWALS ARE
REMOVABLE AND THE PATIENT CAN
GO BACK TO WHERE THEY WERE
BEFORE SO THE BENEFITS CAN BE
LONG LASTING AND PERMANENT4@4@ F
IT WORKS.
BUT IF IT DOESN'T WORK OR
THERE'S A PROBLEMS WE CAN
ALWAYS4@ PLUCK THEM OUT AND
THERE'S NO PERMANENT IMPLANTS
IN THE PATIENT.
ALL RIGHT.
WELL THANK YOU, DR. CPSC FOR
GIVING US SOME INSIGHT ON HOW
THIS NEW TREATMENT WORKS.
IF YOU